Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dietmar Ofner

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Disease Markers|September 10, 2010
14-3-3 sigma and p53 expression in gastric cancer and its clinical applicationsGilbert Mühlmann, Dietmar Ofner, Matthias Zitt, et al.
Lancet (London, England)|April 20, 2004
Methylation changes in faecal DNA: a marker for colorectal cancer screening?Hannes M Müller, Michael Oberwalder, Heidi Fiegl, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinomaAlexander F DeVries, Christian Kremser, Patrick A Hein, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2010
Immunohistochemically detectable dickkopf-3 expression in tumor vessels predicts survival in gastric cancerGilbert Mühlmann, Gerold Untergasser, Matthias Zitt, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 17, 2008
Postoperative morbidity following chemoradiation for locally advanced low rectal cancerIngrid Stelzmueller, Matthias Zitt, Felix Aigner, et al.
Disease Markers|December 20, 2008
Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: a potential diagnostic tool for therapy monitoringMatthias Zitt, Hannes M Müller, Marina Rochel, et al.
Anticancer Research|December 27, 2011
Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II studyWolfgang Eisterer, Alexander DE Vries, Dorota Kendler, et al.
International Journal of Colorectal Disease|July 20, 2007
SFRP2 methylation in fecal DNA--a marker for colorectal polypsMichael Oberwalder, Marion Zitt, Cornelia Wöntner, et al.
The Annals of Thoracic Surgery|May 6, 2014
Emergent pneumonectomy for lung gangrene: does the outcome warrant the procedure?Michael Schweigert, Carlos F Giraldo Ospina, Norbert Solymosi, et al.
The American Surgeon|May 29, 2013
Endoscopic stent insertion versus primary operative management for spontaneous rupture of the esophagus (Boerhaave syndrome): an international study comparing the outcomeMichael Schweigert, Rory Beattie, Norbert Solymosi, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Disease Markers|September 10, 2010
14-3-3 sigma and p53 expression in gastric cancer and its clinical applicationsGilbert Mühlmann, Dietmar Ofner, Matthias Zitt, et al.
Lancet (London, England)|April 20, 2004
Methylation changes in faecal DNA: a marker for colorectal cancer screening?Hannes M Müller, Michael Oberwalder, Heidi Fiegl, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinomaAlexander F DeVries, Christian Kremser, Patrick A Hein, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2010
Immunohistochemically detectable dickkopf-3 expression in tumor vessels predicts survival in gastric cancerGilbert Mühlmann, Gerold Untergasser, Matthias Zitt, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 17, 2008
Postoperative morbidity following chemoradiation for locally advanced low rectal cancerIngrid Stelzmueller, Matthias Zitt, Felix Aigner, et al.
Disease Markers|December 20, 2008
Circulating cell-free DNA in plasma of locally advanced rectal cancer patients undergoing preoperative chemoradiation: a potential diagnostic tool for therapy monitoringMatthias Zitt, Hannes M Müller, Marina Rochel, et al.
Anticancer Research|December 27, 2011
Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II studyWolfgang Eisterer, Alexander DE Vries, Dorota Kendler, et al.
International Journal of Colorectal Disease|July 20, 2007
SFRP2 methylation in fecal DNA--a marker for colorectal polypsMichael Oberwalder, Marion Zitt, Cornelia Wöntner, et al.
The Annals of Thoracic Surgery|May 6, 2014
Emergent pneumonectomy for lung gangrene: does the outcome warrant the procedure?Michael Schweigert, Carlos F Giraldo Ospina, Norbert Solymosi, et al.
The American Surgeon|May 29, 2013
Endoscopic stent insertion versus primary operative management for spontaneous rupture of the esophagus (Boerhaave syndrome): an international study comparing the outcomeMichael Schweigert, Rory Beattie, Norbert Solymosi, et al.
Pageof 4